Primary Dermal Melanoma (PDM): Histological and Clinical Interdependence to Guide Therapy

Hadas Zamir1,2, Meora Feinmesser2,3, Haim Gutman2,4

  • 136631 Dermatology Clinic, Kupat Holim Clalit, Israel.

Abstract

Insights

This study distinguished primary dermal melanoma (PDM) from metastasis, finding that patients benefit from wide local excision and sentinel node biopsy. Complete nodal dissection showed promising outcomes for stage III disease.

Area of Science:

  • Dermatology
  • Oncology
  • Pathology

Background:

  • Distinguishing primary dermal melanoma (PDM) from dermal metastasis is clinically significant.
  • Clinical presentation can mimic metastatic disease, necessitating precise diagnostic criteria.

Purpose of the Study:

  • To examine clinical and histological parameters of PDM for differentiation from dermal metastasis.
  • To evaluate the outcomes of PDM patients treated with wide local excision and sentinel node procedures.

Main Methods:

  • Retrospective analysis of a prospective cohort of 26 patients with PDM (N=9) and clinically diagnosed PDM (cPDM; N=17).
  • Histopathology review and comparison of prognosticators and outcomes between groups.
  • All patients underwent sentinel node retrieval and wide local excision (WLE); completion lymph-node dissection was performed when indicated.

Main Results:

  • The study identified 26 patients with a median age of 69 years. Mean Breslow thickness was 7.9 mm, and mean mitotic rate was 4.9/mm².
  • Sentinel nodes were metastatic in 25% of patients. At a median follow-up of 62 months, 20 patients were disease-free.
  • Six patients died from cPDM, with 5 having ulcerated or epidermal-abutting primary melanomas.

Conclusions:

  • Accurate diagnosis of cPDM requires expert pathology and correlation with clinical findings.
  • Patients appear to benefit from WLE with sentinel node retrieval and complete dissection when appropriate.
  • Complete nodal dissection in PDM is associated with better outcomes, particularly for stage III disease.